| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |